Peer reviewed
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy
Observational retrospective cohort study (Bannister et al.) reporting that metformin-treated patients had lower mortality than matched non-diabetic controls, fueling interest in metformin as a longevity therapeutic.
Diabetes, Obesity and MetabolismPublished 2014-07-16Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- Diabetes, Obesity and Metabolism
- Source type
- Peer reviewed
- Registry ID
bannister-2014-metformin-mortality
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.